Cardiac Biomarker ELISA Kits

Document Sample
Cardiac Biomarker ELISA Kits Powered By Docstoc
					                    Cardiac Biomarker ELISA Kits
                                   Literature Citations

Mouse cTnI Publications

  1. Richer MJ, Lavallée DJ, Shanina I, Horwitz MS (2009) Toll-Like Receptor 3 Signaling on
      Macrophages Is Required for Survival Following Coxsackievirus B4 Infection. PLoS ONE 4(1):
      e4127. doi:10.1371/journal.pone.0004127
  2. Buyse MG, Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the
      dystrophin deficient mdx mouse: cardiac protection and improved exercise performance.
      Eurpoean Heart Journal 30:116-124 (2009)
  3. Elrod JW Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by
      preservation of mitochondrial function. PNAS 104:15560-15565 (2007)
  4. Eckle T, Cardioprotection by Ecto-5'-Nucleotidase (CD73) and A2B Adenosine Receptors.
      Circulation 115:1581-1590 (2007)
  5. Eckle T, Systematic evaluation of a novel model for cardiac ischemic preconditioning in
      mice. Am J Physiol Heart Circ. Physiol. 291:H2533-H2540 (2006)
  6. Hardarson HS, Toll-like receptor 3 is an essential component of the innate stress response
      in virus-induced cardiac injury. Am J Physiol Heart Circ. Physiol 292:H251-H258 (2006)
  7. Madonna R, Rinaldi L, Rossi C, Geng Y-J and De Caterina R. Prostacyclin improves transcoronary
      myocardial delivery of adipose tissue-derived stromal cells. Clinical Research 27:2054-2061
  8. Morrison RR, Tan XL, Ledent C, Mustafa SJ and Hifmann PA. Targeted deletion of A2A adenosine
      receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart
      Circ Physiol. 293:H2523-H2529 (2007)
  9. Engle, SK et al. Strain differences in serum cardiac troponin-I concentration and myocardial
      necrosis after isoproterenol treatment in mice. Abstract No. 383. The Toxicologist CD — An
      official Journal of the Society of Toxicology, Volume 96, Number S-1, March 2007.
  10. Hou G, Dick R, Zeng C, Brewer GJ., Comparison of lowering copper levels with
      tetrathiomolybdate and zinc on mouse tumor and doxorubicin models. Translational Research
      148:309-314 (2006)
  11. Huber SA, Feldman AM and Sartini D., Coxsackievirus B3 induces T regulatory cells, which inhibit
      cardiomyopathy in tumor necrosis factor-a transgenic mice. Circ Res. 99:1109-1116 (2006)
  12. Mullick A, Leon Z, Min-Oo G, Berghout J, Lo R, Daniels E and Gros P. Cardiac failure in C5-
      deficient mice after Candida albicans infection. Infection and Immunity. 74(8):4439-4451 (2006)
  13. Hou G, Dick R, Abrams GD, Brewer GJ., Tetrathiomolybdate protects against cardiac damage by
      doxorubicin in mice. J Lab Clin Med.146(5):299-303 (2005
  14. Tao L, Liu H-R, Gao F, Qu Y, Christopher TA, Lopez BL and Ma XL. Mechanical traumatic injury
      without circulatory shock causes cardiomyocyte apoptosis: rol of reactive nitrogen and reactive
      oxygen species. Am J Heart Circ Physiol. 288:H2811-H2818 (2005)

Rat cTnI Publications

  1. Yue T-L, In vivo activation of peroxisome proliferator-activated redeptor-d protects the
     heart from ischemia/reperfusion injury in Zucker fatty rats. J. Pharm. Exp. Ther. 325:466-474
  2. Zagorski J, Gellar MA, Obraztsova M, Kline JA and Watts JA. Inhibition of CINC-1 decreases right
     ventricular damage caused by experimental pulmonary embolism in rats. The Journal of
     Immunology 179:7820-7826 (2007)
  3. Legare JF, Oxner A, Heimrath O, Myers T and Currie RW. Heat Shock treatment results in
     increased recruitment of labeled PMN following myocardial infarction. Am J Physiol Heart Circ
     Physiol. 293(5):H3210-5 (2007)
  4. Chopra M and Sharma AC. Distinct cardiodynamic and molecular chracteristics during early and
     late stages of sepsis-induced myocardial dysfunction. Life Sciences. epub. July 2007
  5. Liu J, Pang Y, Chang T, Bounelis P, Chatham JC, and Marchase RB. Increased hexoseamine
     biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium
     paradox and ischemia. J Mol. Cell Cardiol. 40 303-312 (2006)
  6. Wang P and Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved
     recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab
     286:E725-E736 (2004)

Rabbit cTnI Publications

  1. Booth EA, and Lucchesi BR. Medroxyprogesterone acetate prevents the cardioprotective and anti-
     inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and
     reperfusion. Am J Physiol Heart Circ Physiol. 293(3):H1408-15 (2007)
  2. Lauver DA, Booth EA, White AJ, Poradosu E & Lucchesi BR. Sulodexide attenuates myocardial
     ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without
     affecting hemostasis. J Pharm. Exp. Ther. 312(2):794-800 (2005)
  3. Lauver DA, Lockwood SF and Lucchesi BR. Disodium disuccinate astaxanthin (Cardax) attenuates
     complement activation and reduces myocardial injury following ischemia/reperfusion. J Pharm.
     Exp. Ther. 314(2):686-692 (2005)
  4. Booth EA, Obeid NR and Lucchesi BR. Activation of estrogen receptor-alpha protects the in vivo
     rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 289(5):H2039-47

Pig cTnI Publications

  1. Wu D, Bassuk J, Arias J, Doods H and Adams JA. Cardiovascular effects of Na+/H+ exchanger
     inhibition with BIIB513 following hypovolemic circulatory shock. Shock 23(3):269-274 (2005)
  2. Osipov RM, Effect of hydrogen sulfide on myocardial protection in the setting of
     cardioplegia and cardiopulmonary bypass. Interactive CardioVascular and Thoracic Surgery 10:
     506-512 (2010)
  3. Adams JA, Periodic acceleration (pGz) prior to whole body ischemia reperfusion injury
     provides early cardioprotective preconditioning. Life Sciences 86: 707-715 (2010)

Monkey cTnI Publications

  1. Minimo H, Characteristics of troponins as myocardial damage biomarkers in cynomolgus
     monkeys. J. Toxicol. Sci. 34(6): 589-601 (2009)